Mark Lesselroth, president and CEO of BioPortUSA was recently asked to join the Advisory Board of PeriVision, a Swiss MedTech start-up focused on the Ophthalmic market.[...]
Mark Lesselroth, president and CEO of BioPortUSA was recently asked to join the Advisory Board of PeriVision, a Swiss MedTech start-up focused on the Ophthalmic market.[...]
On January 27, Mark Lesselroth, president and CEO of BioPortUSA will participate at a Fireside chat for members of the bayern innovative MedTech Pharma Forum on Market Entry U.S.A.[...]
MEDICA the world’s largest medical device show, will once again be meeting in person. Running parallel to the exhibit will be the Medical Tech conference which is managed by the leading industry associations SPECTARIS and ZVEI. Here you will learn about the German and international market environment, as well as the implementation of modern procedures and methods in clinical practice.[...]
Perivision (https://perivision.io/), a Swiss Start-Up focused on the Ophthalmic side of medicine, recently asked BioPortUSA for help with the reimbursement side of things in the USA.[...]
Mark Lesselroth joins host Bill Kenney from MEET to uncover the myths and learn the realities for Life Science companies entering the US Market.[...]
From September 26 to October 1st, the exceptional Swiss National Startup Teams of the Venture Leaders Life Sciences 2020 and Medtech 2021 had their residence at Swissnex Boston for a joint roadshow: 17 top-class startups presented their innovations to international investors, fine-tuned their pitches, and participated in a series of business development workshops to deepen their knowledge of the American market and regulations. Let's immerse ourselves in this highly inspiring atmosphere.[...]
The team at BioPortUSA has been asked to present to a group of 17 Swiss Medical Device start-ups on what it takes to be successful in the USA including how to navigate the regulatory pathway. [...]
Social Media